The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Cue Biopharma, Inc. insider acquisitions

Company CIK 0001645460 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
CUE · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Sarraf PashaSarraf PashaSandercock ColinSandercock ColinWarren LucindaWarren LucindaBaker Daniel G.Baker Daniel G.Sarraf Pasha · December 30, 2025 · Purchase · Common StockSarraf Pasha · December 30, 2025 · Purchase · Common StockSarraf Pasha · December 30, 2025 · Purchase · Common StockSarraf Pasha · December 30, 2025 · Purchase · Common StockSarraf Pasha · December 30, 2025 · Purchase · Common StockSandercock Colin · December 3, 2025 · Stock award · Stock Option (right to buy)Sandercock Colin · September 26, 2025 · Stock award · Stock Option (right to buy)Warren Lucinda · September 29, 2025 · Stock award · Stock Option (right to buy)Baker Daniel G. · September 29, 2025 · Stock award · Stock Option (right to buy)Sep 26, 2025Dec 30, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

9 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 30, 2025Cue Biopharma, Inc.Common StockSarraf PashaPurchase
Dec 30, 2025Cue Biopharma, Inc.Common StockSarraf PashaPurchase
Dec 30, 2025Cue Biopharma, Inc.Common StockSarraf PashaPurchase
Dec 30, 2025Cue Biopharma, Inc.Common StockSarraf PashaPurchase
Dec 30, 2025Cue Biopharma, Inc.Common StockSarraf PashaPurchase
Dec 3, 2025Cue Biopharma, Inc.Stock Option (right to buy)Sandercock ColinStock award
Sep 26, 2025Cue Biopharma, Inc.Stock Option (right to buy)Sandercock ColinStock award
Sep 29, 2025Cue Biopharma, Inc.Stock Option (right to buy)Warren LucindaStock award
Sep 29, 2025Cue Biopharma, Inc.Stock Option (right to buy)Baker Daniel G.Stock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

CUE · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Sarraf PashaDirector
PurchaseCommon StockNon-derivative security · Code P77,4170.3016Value: 23,348.9672Currency not specifiedView ↗
Trade:
Sarraf PashaDirector
PurchaseCommon StockNon-derivative security · Code P78,1160.3114Value: 24,325.3224Currency not specifiedView ↗
Trade:
Sarraf PashaDirector
PurchaseCommon StockNon-derivative security · Code P86,9470.3174Value: 27,596.9778Currency not specifiedView ↗
Trade:
Sarraf PashaDirector
PurchaseCommon StockNon-derivative security · Code P77,1480.3003Value: 23,167.5444Currency not specifiedView ↗
Trade:
Sarraf PashaDirector
PurchaseCommon StockNon-derivative security · Code P4,2290.3094Value: 1,308.4526Currency not specifiedView ↗
Trade:
Sandercock ColinSVP, GENERAL COUNSEL
Stock awardStock Option (right to buy)Derivative security · Code A70,0000Value: 0Currency not specifiedView ↗
Trade:
Sandercock ColinSVP, GENERAL COUNSEL
Stock awardStock Option (right to buy)Derivative security · Code A30,0000Value: 0Currency not specifiedView ↗
Trade:
Warren LucindaCHIEF BUSINESS OFFICER
Stock awardStock Option (right to buy)Derivative security · Code A125,0000Value: 0Currency not specifiedView ↗
Trade:
Baker Daniel G.CHIEF DEVELOPMENT OFFICER
Stock awardStock Option (right to buy)Derivative security · Code A50,0000Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →